GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
companies in this sector in the United States:
Merck & Co. , Inc.
sales of $39.81 billion
of which 88%
was Merck Pharmaceutical),
of which 100%
was Pharmaceutical Products), and
of which 84%
During the year ended December of 2016, sales at
GlaxoSmithKline plc were $37.50 billion.
increase of 2.8%
versus 2015, when the company's sales were $36.48 billion.
Despite this increase, sales are still
below the level achieved in 2014, when GlaxoSmithKline plc
reported sales of $37.87 billion.
Sales of Vaccines saw an increase
that was more than double the company's growth rate: sales were up
10.7% in 2016, from
$5.58 billion to $6.17 billion.
GlaxoSmithKline plc also saw significant increases in sales in
Consumer Healthcare (up 5.2% to $9.67 billion)